Stamaril
Active ingredient not listed in the SAHPRA register
Sanofi-aventis South Africa (Pty) Ltd
Registration
- Applicant
- Sanofi-aventis South Africa (Pty) Ltd
- Certificate holder
- Sanofi-aventis South Africa (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Stamaril EACH 0,5 ml DOSE CONTAINS YELLOW FEVER VIRUS AT LEAST 1000 MOUSE LD50 LIVE, ATTENUATED VIRUS STRAIN 17 D/AB 237 | 0,5 mLPowder and solvent for suspension for injection | 27053227/30.1/0532Approved 13 December 2021 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
The SAHPRA register lists no active ingredient for this product, so there is no compound to show.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.